US 6,982,363 B1
UDP-glucose modifiers
Omolayo O. Famodu, Newark, Del. (US); and Richard W. Pearlstein, Newark, Del. (US)
Assigned to E.I. du Pont de Nemours and Company, Wilmington, Del. (US)
Appl. No. 9/913,060
PCT Filed Feb. 09, 2000, PCT No. PCT/US00/03513
§ 371(c)(1), (2), (4) Date Aug. 08, 2001,
PCT Pub. No. WO00/47748, PCT Pub. Date Aug. 17, 2000.
Claims priority of provisional application 60/119588, filed on Feb. 10, 1999.
Int. Cl. A01H 1/00 (2006.01); C07H 21/04 (2006.01); C07K 14/415 (2006.01); C12N 5/14 (2006.01); C12N 9/00 (2006.01)
U.S. Cl. 800—295 11 Claims
 
1. An isolated nucleic acid comprising a polynucleotide consisting of:
(a) a nucleotide sequence encoding a polypeptide having UDP-glucose pyrophosphorylase activity, wherein the polypeptide has an amino acid sequence of at least 90% sequence identity, based on the Clustal V method of alignment, when compared to SEQ ID NO:10, or
(b) a full-length complement of the nucleotide sequence of (a).